Dual-tasking for Individuals With Lower Limb Amputation: Exploring the Relationship to Falls and Instrumental Activities of Daily Living
DIAL
Dual-Tasking for Individuals With Lower Limb Amputation: Exploring the Relationship to Falls and Instrumental Activities of Daily Living
2 other identifiers
observational
48
1 country
1
Brief Summary
Veterans with dysvascular lower limb amputation (LLA) have a high fall risk, which persists despite completion of conventional rehabilitation. The presence of fall risk could be a primary reason for the high disability and low quality of life outcomes in this Veteran population. A potential novel intervention for this population is to train performance of tasks that require both physical and cognitive attention (i.e., dual-tasking). Therefore, the purpose of this study is to explore relationships between dual-task performance and self-reported falls for Veterans with dysvascular LLA. Further, dual-tasking occurs during everyday life and this project will examine the association between dual-task performance and participation in activities of daily living (basic and instrumental). The results will form the foundation for development and future study of a novel dual-task training program for Veterans with dysvascular LLA.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Dec 2021
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 1, 2021
CompletedFirst Posted
Study publicly available on registry
November 15, 2021
CompletedStudy Start
First participant enrolled
December 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedMarch 15, 2024
March 1, 2024
2 years
November 1, 2021
March 13, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Dual-task Performance
Dual-task performance will be classified into one of 4 categories (gait priority trade off, cognitive priority trade off, mutual interference, or mutual facilitation) based on performance in 3 different 2-minute conditions (gait single task, cognitive single task, dual-task). The gait task will be overground walking on a 12 meter obstacle-free course with a 1 meter turning area. Gait speed (m/s) will be calculated using the total distance covered over the 2 minutes. The cognitive task will be serial subtractions of seven, starting between 590-599. A corrected response rate will be calculated as: responses per second\*percent of correct responses. Dual-task performance will represent a participant's performance on improvement or decline on both gait and cognitive performance comparing single and dual-tasking. For example, mutual interference would be a decline in both gait (slower speed), and cognitive (lower corrected response ratio) from single to dual-tasking.
Baseline
Secondary Outcomes (3)
Self-reported falls
Baseline
Modified Barthel Index
Baseline
Frenchay Activities Index
Baseline
Study Arms (1)
Veterans with Dysvascular Lower Limb Amputation
Self-report assessments, performance-based assessments, and optional individual interview with Veterans with dysvascular lower limb amputation.
Eligibility Criteria
Veterans with dysvascular lower-limb amputation
You may qualify if:
- unilateral, transtibial, or transfemoral LLA
- diagnosis of diabetes mellitus or peripheral artery disease
- age 50 to 89 years
- able to ambulate around the home with or without an assistive device
- at least one year since LLA
You may not qualify if:
- trauma or cancer-related etiology of the LLA
- decisionally challenged individuals (SLUMS score in "Dementia" range)
- prisoners
- active cancer treatment
- clinical discretion of principle investigator to exclude patients who are determined to be unsafe and/or inappropriate to participate in the described intervention
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Rocky Mountain Regional VA Medical Center, Aurora, CO
Aurora, Colorado, 80045, United States
Biospecimen
no biospecimen retention
Study Officials
- PRINCIPAL INVESTIGATOR
Laura A. Swink, PhD
Rocky Mountain Regional VA Medical Center, Aurora, CO
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 1, 2021
First Posted
November 15, 2021
Study Start
December 1, 2021
Primary Completion
November 30, 2023
Study Completion
December 31, 2023
Last Updated
March 15, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will not share
When results are published a final de-identified, anonymized data set may be made available to the public, based on availability of resources for the given journal publisher. Care will be taken to ensure that individuals cannot be re-identified in the dataset, with no inclusion of or links to personally identifiable information.